US Patent 12004868 Liposomal mitigation of drug-induced inhibition of the cardiac I
Patent 12004868 was granted and assigned to Signpath Pharma on June, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 12 Jun, 2024
Golden AI
Edits made to:
Infobox (+37 properties)
Article (+307 characters)
US Patent 12004868 Liposomal mitigation of drug-induced inhibition of the cardiac I
Article
Patent abstract
Compositions and methods are provided for preventing one or more cardiac channelopathies or conditions resulting from irregularities or alterations in cardiac patterns, or both, in a human or animal subject comprising: one or more pharmacologically active agents that causes at least one of I
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Annie Bouchard0
George M. Shopp0
Lawrence Helson0
Date of Patent
June 11, 2024
0Patent Application Number
164324980
Date Filed
June 5, 2019
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 12004868 Liposomal mitigation of drug-induced inhibition of the cardiac I
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
